ArticleClinical and translational medicine2021

SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases.

Weijun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.